Up a level |
Ramanan, Athimalaipet V, Dick, Andrew D, Guly, Catherine, McKay, Andrew ORCID: 0000-0003-1312-8911, Jones, Ashley P, Hardwick, Ben, Lee, Richard WJ, Smyth, Matthew, Jaki, Thomas, Beresford, Michael W ORCID: 0000-0002-5400-9911 et al (show 1 more authors)
(2020)
Tocilizumab in patients with anti-TNF refractory juvenile idiopathic arthritis-associated uveitis (APTITUDE): a multicentre, single-arm, phase 2 trial.
The Lancet Rheumatology, 2 (3).
e135-e141.
Ramanan, Athimalaipet V, Dick, Andrew D, Jones, Ashley P, Guly, Catherine, Hardwick, Ben, Hickey, Helen ORCID: 0000-0003-0467-0362, Lee, Richard, McKay, Andrew ORCID: 0000-0003-1312-8911 and Beresford, Michael W ORCID: 0000-0002-5400-9911
(2018)
A phase II trial protocol of Tocilizumab in anti-TNF refractory patients with JIA-associated uveitis (the APTITUDE trial).
BMC RHEUMATOLOGY, 2 (1).
4-.